Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP739201.RABfHVmwMrVeTye3yHiZQKOaKwrgnBiHTLwIH9mWirqWg130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739201.RABfHVmwMrVeTye3yHiZQKOaKwrgnBiHTLwIH9mWirqWg130_provenance.
• NP761089.RAZY3fbCNcLnzTgDLykhjNtoABxlXKY04fL40QhOso88k130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761089.RAZY3fbCNcLnzTgDLykhjNtoABxlXKY04fL40QhOso88k130_provenance.
• NP873670.RA-JEAUtoGU34nwin5DSex0MPtaRbo45t8BVlBUbFzlvQ130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873670.RA-JEAUtoGU34nwin5DSex0MPtaRbo45t8BVlBUbFzlvQ130_provenance.
• NP761103.RAH8nN8pyhXTTU6pnRcHq6MUBCrviVYwhGyYZCIMt7rks130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761103.RAH8nN8pyhXTTU6pnRcHq6MUBCrviVYwhGyYZCIMt7rks130_provenance.
• NP707904.RAI6yz6cSTrfxXEvASzOydYnf-SCEE8nk2r5e7NTsp1v4130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707904.RAI6yz6cSTrfxXEvASzOydYnf-SCEE8nk2r5e7NTsp1v4130_provenance.
• NP707947.RAP2qXW1hF47KPAwzC3fOapOQIp6SUbJ_9I7QqGyyXZa0130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707947.RAP2qXW1hF47KPAwzC3fOapOQIp6SUbJ_9I7QqGyyXZa0130_provenance.
• NP708173.RAN0kUx-QBv8r6sk9edoVKrxSaVx6cjy8kdKTAS2yujUM130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708173.RAN0kUx-QBv8r6sk9edoVKrxSaVx6cjy8kdKTAS2yujUM130_provenance.
• NP873669.RAT8UtHlVz45n8lUCnEiHuEeBKJEdpUkbUCFf_mN-d6rM130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873669.RAT8UtHlVz45n8lUCnEiHuEeBKJEdpUkbUCFf_mN-d6rM130_provenance.
• NP873672.RAeYCTxLevaJT7Heq--2FnIwUcDPzCVbE9K9z9GYN7U-o130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873672.RAeYCTxLevaJT7Heq--2FnIwUcDPzCVbE9K9z9GYN7U-o130_provenance.
• NP739162.RAOg3b6gT8y_CSTo5PR-0WHSJQhzIBChKRarBJxlApI1c130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739162.RAOg3b6gT8y_CSTo5PR-0WHSJQhzIBChKRarBJxlApI1c130_provenance.
• assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP873675.RAIB5ZtSvV9inrmiK4zysJN9Pdve5eHtW6Za4Hw1dN0iE130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873675.RAIB5ZtSvV9inrmiK4zysJN9Pdve5eHtW6Za4Hw1dN0iE130_provenance.
• NP708256.RAtHHdgYXtpGxIhDskdFOx9edSk8Voe5EFAOyJD_1Lnk8130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708256.RAtHHdgYXtpGxIhDskdFOx9edSk8Voe5EFAOyJD_1Lnk8130_provenance.
• NP873664.RAhjjplirHgv4lIsVlow2h5Z7URypgbP0SlSHgYw9hG4s130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873664.RAhjjplirHgv4lIsVlow2h5Z7URypgbP0SlSHgYw9hG4s130_provenance.
• NP873666.RAg6_TSC0VUL66tFpKFJcOgnv9_DeDIh-mBk-5pebBDbw130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873666.RAg6_TSC0VUL66tFpKFJcOgnv9_DeDIh-mBk-5pebBDbw130_provenance.
• NP873667.RAv8s3FTcIkfagLHxuHJICwG_m_tcD0rjS_2g9E68S92k130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873667.RAv8s3FTcIkfagLHxuHJICwG_m_tcD0rjS_2g9E68S92k130_provenance.
• NP873668.RAs0sozXaRfXye6VlVQsxcJs1Gchz-ZxZF0SdQgVypojw130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873668.RAs0sozXaRfXye6VlVQsxcJs1Gchz-ZxZF0SdQgVypojw130_provenance.
• NP873671.RApSNCztQ4paOkr0F25pJMMnVFtb5Je1H39f_jXdMBJCY130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873671.RApSNCztQ4paOkr0F25pJMMnVFtb5Je1H39f_jXdMBJCY130_provenance.
• NP873674.RAnLBW1R54ROXOfR2dhdnNUhpk8qahu5FFPN9hMIXZeVs130_assertion description "[In addition, we examined a large spectrum of lung cancer entities with neuroendocrine differentiation (ie, small cell cancers, large cell cancers, typical and atypical carcinoids) for SOX2 and TTF1 copy number gains to reveal potential molecular ties to squamous cell carcinomas or adenocarcinomas of the lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873674.RAnLBW1R54ROXOfR2dhdnNUhpk8qahu5FFPN9hMIXZeVs130_provenance.